The G-BA has specified the drug combination of a calcium channel blocker (amlodipine or nitrendipine) and an ACE inhibitor (lisinopril, ramipril or enalapril) as the appropriate comparator therapy.

The calcium channel blocker amlodipine decreases the risk of cardiovascular events (such as heart attack or heart-disease related deaths) in patients with coronary artery disease and normal blood ...